If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
BORTEZOM bortezomib 3.5 mg powder for injection vial AUST R: 214246Active ingredients:
bortezomib
Dosage form:
Injection, powder for
Sponsor:
Pharmacor Pty Ltd
Phone:
1300138805
|
From
01 Jan 2025
to
01 Mar 2025
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Manufacturing
Management action:
Alternative generic products are available.
|
BORTEZOMIB BAXTER bortezomib 3.5 mg powder for injection vial AUST R: 379611Active ingredients:
bortezomib
Dosage form:
Injection, powder for
Sponsor:
Baxter Healthcare Pty Ltd
Phone:
1300302409
|
Deletion from market:
31 May 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|
BORTEZOMIB JUNO bortezomib 1mg powder for injection vial AUST R: 283340Active ingredients:
bortezomib
Dosage form:
Injection, powder for
Sponsor:
Juno Pharmaceuticals Pty Ltd
Phone:
+61 3 8888 1288
|
Deletion from market:
01 Jul 2024
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic product is available.
|
BORTEZOMIB-TEVA bortezomib 3.5 mg powder for injection vial AUST R: 293593Active ingredients:
bortezomib
Dosage form:
Injection, powder for
Sponsor:
Teva Pharma Australia Pty Ltd
Phone:
1800 288 382
|
Deletion from market:
30 Nov 2024
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|
DBL BORTEZOMIB 2.5 mg powder for injection vial AUST R: 275710Active ingredients:
bortezomib
Dosage form:
Injection, powder for
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800-675-229
|
Deletion from market:
01 Oct 2024
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An alternative product is available.
|
VELCADE bortezomib 3.5 mg powder for injection vial AUST R: 104542Active ingredients:
bortezomib
Dosage form:
Injection, powder for
Sponsor:
Janssen-Cilag Pty Ltd
Phone:
1800226334
|
Deletion from market:
30 Jun 2025
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|